Related Experiment Video
Updated: Apr 24, 2026
06:23
Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss
Published on: April 24, 2020
4.7K
Cell-based approach for treatment of corneal endothelial dysfunction
Naoki Okumura1, Shigeru Kinoshita, Noriko Koizumi
1*Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan; and †Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Cornea
|September 5, 2014
Summary
A novel cell culture protocol and Rho-kinase inhibitor allow transplantation of corneal endothelial cells (CECs) as a cell suspension, overcoming donor cornea shortages for treating corneal endothelial dysfunction.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Tissue Engineering
Background:
- Corneal endothelial dysfunction leads to vision loss and blindness.
- Corneal transplantation is limited by donor cornea scarcity.
- Tissue engineering offers a promising alternative for corneal endothelial dysfunction treatment.
Purpose of the Study:
- To address challenges in corneal endothelial cell (CEC) culture and transplantation.
- To present a novel cell culture protocol and transplantation technique for CECs.
- To update on the clinical status of cell-based therapies for corneal endothelial dysfunction.
Main Methods:
- Developed a novel cell culture protocol for corneal endothelial cells (CECs).
- Utilized a Rho-kinase inhibitor to modulate CEC adhesion properties.
- Investigated transplantation of CECs in cell suspension form without a carrier.
Main Results:
- The novel protocol improved CEC culture, overcoming senescence and fibroblastic transformation.
- Modulation of CEC adhesion enabled successful transplantation in cell suspension.
- This approach bypasses the need for a carrier material during transplantation.
Conclusions:
- A new method for culturing and transplanting corneal endothelial cells (CECs) has been developed.
- This technique holds potential to overcome the donor cornea shortage.
- Cell-based therapy for corneal endothelial dysfunction is advancing towards clinical application.
